Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.56 USD | -4.04% | -6.56% | -31.93% |
May. 15 | Eagle Pharmaceuticals, Inc. Enters into a Third Amendment to Third Amended and Restated Credit Agreement | CI |
May. 06 | North American Morning Briefing : Stock Futures -2- | DJ |
Business Summary
Number of employees: 134
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Injectable Drugs
100.0
%
| 172 | 100.0 % | 317 | 100.0 % | +84.56% |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 172 | 100.0 % | 317 | 100.0 % | +84.56% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Graves
CEO | Chief Executive Officer | 61 | 13-10-31 |
Steven B. Ratoff
DFI | Director of Finance/CFO | 81 | 07-02-28 |
Ryan Debski
CMP | Compliance Officer | - | 21-04-30 |
Reed McClung
PRN | Corporate Officer/Principal | - | - |
John Kimmet
SAM | Sales & Marketing | - | 19-12-31 |
Debra M. Hussain
PRN | Corporate Officer/Principal | - | 22-07-17 |
Daniel O'Connor
PRN | Corporate Officer/Principal | - | 06-12-31 |
Charles Wescott
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Steven B. Ratoff
DFI | Director of Finance/CFO | 81 | 07-02-28 |
Jennifer Simpson
BRD | Director/Board Member | 55 | 19-08-27 |
Richard Edlin
BRD | Director/Board Member | 63 | 17-03-16 |
Michael Graves
CEO | Chief Executive Officer | 61 | 13-10-31 |
Robert Glenning
BRD | Director/Board Member | 63 | 16-06-30 |
Luciana Borio
BRD | Director/Board Member | 53 | 21-04-27 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 17,539,701 | 11,425,564 ( 65.14 %) | 4,552,730 ( 25.96 %) | 65.14 % |
Company contact information
Eagle Pharmaceuticals, Inc.
50 Tice Boulevard Suite 315
07677-9991, Woodcliff Lake
+201 326 5300
http://www.eagleus.comSector
1st Jan change | Capi. | |
---|---|---|
-31.93% | 48.18M | |
+19.29% | 80.5B | |
+15.08% | 9.15B | |
-18.33% | 4.9B | |
+43.39% | 4.49B | |
+13.95% | 4.44B | |
+10.89% | 2.19B | |
-28.40% | 2.13B | |
+15.93% | 2.1B | |
-43.17% | 1.78B |
- Stock Market
- Equities
- EGRX Stock
- Company Eagle Pharmaceuticals, Inc.